JD Health International Inc.

SEHK:6618 Stock Report

Market Cap: HK$84.8b

JD Health International Balance Sheet Health

Financial Health criteria checks 6/6

JD Health International has a total shareholder equity of CN¥49.4B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥64.3B and CN¥14.9B respectively. JD Health International's EBIT is CN¥630.8M making its interest coverage ratio -0.3. It has cash and short-term investments of CN¥40.5B.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-0.3x
CashCN¥40.49b
EquityCN¥49.37b
Total liabilitiesCN¥14.92b
Total assetsCN¥64.29b

Recent financial health updates

No updates

Recent updates

JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors

Apr 17
JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors

JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return

Apr 08
JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return

At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?

Mar 01
At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?

Revenues Tell The Story For JD Health International Inc. (HKG:6618)

Jan 16
Revenues Tell The Story For JD Health International Inc. (HKG:6618)

JD Health International (HKG:6618) Will Want To Turn Around Its Return Trends

Dec 07
JD Health International (HKG:6618) Will Want To Turn Around Its Return Trends

What Does JD Health International Inc.'s (HKG:6618) Share Price Indicate?

Nov 20
What Does JD Health International Inc.'s (HKG:6618) Share Price Indicate?

JD Health International Inc. (HKG:6618) Shares Could Be 44% Below Their Intrinsic Value Estimate

Nov 02
JD Health International Inc. (HKG:6618) Shares Could Be 44% Below Their Intrinsic Value Estimate

Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital

Aug 21
Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital

JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 32% Above Its Share Price

Aug 03
JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 32% Above Its Share Price

JD Health International Inc.'s (HKG:6618) Price In Tune With Revenues

Jun 08
JD Health International Inc.'s (HKG:6618) Price In Tune With Revenues

Is JD Health International Inc. (HKG:6618) Trading At A 32% Discount?

Apr 19
Is JD Health International Inc. (HKG:6618) Trading At A 32% Discount?

Estimating The Intrinsic Value Of JD Health International Inc. (HKG:6618)

Dec 29
Estimating The Intrinsic Value Of JD Health International Inc. (HKG:6618)

Is There An Opportunity With JD Health International Inc.'s (HKG:6618) 31% Undervaluation?

Sep 14
Is There An Opportunity With JD Health International Inc.'s (HKG:6618) 31% Undervaluation?

A Look At The Fair Value Of JD Health International Inc. (HKG:6618)

Dec 04
A Look At The Fair Value Of JD Health International Inc. (HKG:6618)

Calculating The Fair Value Of JD Health International Inc. (HKG:6618)

Mar 08
Calculating The Fair Value Of JD Health International Inc. (HKG:6618)

Financial Position Analysis

Short Term Liabilities: 6618's short term assets (CN¥47.8B) exceed its short term liabilities (CN¥14.6B).

Long Term Liabilities: 6618's short term assets (CN¥47.8B) exceed its long term liabilities (CN¥333.0M).


Debt to Equity History and Analysis

Debt Level: 6618 is debt free.

Reducing Debt: 6618 had no debt 5 years ago.

Debt Coverage: 6618 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 6618 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.